GU Cancers 2020 | Bladder: neoadjuvant immunotherapy & ctDNA

VJOncology is committed to improving our service to you

Petros Grivas

Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses his research highlights from the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Grivas specifically mentions data from the ABACUS trial (NCT02662309), the PURE-01 trial (NCT02736266) , the BLASST-01 trial (NCT03294304), as well as trials investigating enfortumab vedotin and erdafitinib.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter